This study aims to analyse Italian Internet users' comments on two posts that appeared on the Facebook page of the Italian newspaper Il Corriere della Sera during a particularly critical phase of the COVID-19 pandemic (specifically, March 2021). At that time, the AstraZeneca vaccine had been temporarily suspended in some European countries due to confirmed reports of blood clots but subsequently declared “safe and effective” by the European Medicines Agency. Two datasets of comments were collected and analysed by combining automatic and manual, as well as quantitative and qualitative, methods. The main findings shed light on the orientation (agreement vs disagreement), construction of consensus and dissent, and epistemic positioning of Facebook users when they are confronted and engaged in dialogue with uncertain news about public health issues.

'The benefits of the vaccine outweigh the risks… they say' Italian Facebook users' comments on the AstraZeneca vaccine suspension

Riccioni I.;Bertolazzi A.;Bongelli R.
2024-01-01

Abstract

This study aims to analyse Italian Internet users' comments on two posts that appeared on the Facebook page of the Italian newspaper Il Corriere della Sera during a particularly critical phase of the COVID-19 pandemic (specifically, March 2021). At that time, the AstraZeneca vaccine had been temporarily suspended in some European countries due to confirmed reports of blood clots but subsequently declared “safe and effective” by the European Medicines Agency. Two datasets of comments were collected and analysed by combining automatic and manual, as well as quantitative and qualitative, methods. The main findings shed light on the orientation (agreement vs disagreement), construction of consensus and dissent, and epistemic positioning of Facebook users when they are confronted and engaged in dialogue with uncertain news about public health issues.
2024
John Benjamins Publishing Company
Internazionale
https://www.jbe-platform.com/content/journals/10.1075/ld.00173.ric
File in questo prodotto:
File Dimensione Formato  
Riccioni_benefits_vaccine_2024.pdf

solo utenti autorizzati

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati
Dimensione 558.55 kB
Formato Adobe PDF
558.55 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11393/334351
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact